Top 93 alternative sites to harpoontx.com
-
azul3d.com
-
neubasetherapeutics.com
-
plustherapeutics.com
-
stoketherapeutics.com
-
bioxceltherapeutics.com
-
plustherapeutics.com
-
stoketherapeutics.com
-
markertherapeutics.com
-
bioeclipse.com
-
genelux.com
-
cuebiopharma.com
-
cardiffoncology.com
-
venntherapeutics.com
-
amunix.com
-
americangene.com
-
beigene.com
-
wellstattherapeutics.com
-
flashtherapeutics.com
-
onconova.com
-
eurekatherapeutics.com
-
iontas.co.uk
-
orphomed.com
-
vescortx.com
-
ikenaoncology.com
-
helixbiopharma.com
-
oncternal.com
-
immucan.eu
-
keyoncologics.co.za
-
zumutor.com
-
viewpointtherapeutics.com
-
crownbio.com
-
g1therapeutics.com
-
4basecare.com
-
rapt.com
-
intelliatx.com
-
tessacell.com
-
interna-technologies.com
-
procella.se
-
gammadeltatx.com
-
cartesiantherapeutics.com
-
ebvdt.nl
-
cgen.com
-
verypowerfulbiology.com
-
beyondspringpharma.com
-
antlera.com
-
systimmune.com
-
xilis.com
-
kymab.com
-
azurrx.com
-
alexza.com
-
genprex.com
-
iksuda.com
-
ethris.com
-
acmbiolabs.com
-
atarabio.com
-
altimmune.com
-
medicago.com
-
royerbiomedical.com
-
vtvtherapeutics.com
-
kloxtechnologies.com
-
aidgenomics.com
-
sylentis.com
-
polypid.com
-
sola-bio.com
-
intuitivetherapeutics.ch
-
intuitiveplan.ch
-
intuitivetherapy.ch
-
intuitivetreatment.ch
-
adalta.com.au
-
bluefieldproject.org
-
iwirc.com
-
eurekaconnectme.com
-
ltcreit.com
-
mozart-tx.com
-
novomedix.com
-
zosanopharma.com
-
cgoncology.com
-
allakos.com
-
americancollegeofbankruptcy.com
-
vir.bio
-
nkartatx.com
-
geron.com
-
ultragenyx.com
-
chinooktx.com
-
plexxikon.com
-
cariboubio.com
-
adicetbio.com
-
corvuspharma.com
-
dynavax.com
-
blademed.com
-
neoleukin.com
-
tempesttx.com
-
cpii.com
Azul 3D: Your Future Factory is Here
Azul 3D™ is a leading-edge 3D printing company, transforming manufacturing with proprietary High Area Rapid Printing (HARP™) technology.
Home | NeuBase Therapeutics, Inc.
Plus Therapeutics, Inc.
Plus Therapeutics' mission is to become the world's leader in developing better and safer nanoscale oncology drugs to improve survival and quality of life for both pediatric and adult patients.
Home - Stoke Therapeutics
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics is developing high value therapeutics in neuroscience and immuno-oncology utilizing a novel artificial intelligence platform.
Plus Therapeutics, Inc.
Plus Therapeutics' mission is to become the world's leader in developing better and safer nanoscale oncology drugs to improve survival and quality of life for both pediatric and adult patients.
Home - Stoke Therapeutics
Marker Therapeutics, Inc. - Pioneering a Multi-Antigen Approach
Our therapy has been used to treat over 150 patients in seven different clinical trials in both blood malignancies and solid tumors
BioEclipse Therapeutics™ | NEXT GENERATION OF IMMUNOTHERAPY
BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics.
Genelux Corporation
BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics.
Immune Responses, On Cue - Cue Biopharma
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) is designed to harness the body’s intrinsic […]
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Venn Therapeutics | Venn Therapeutics
Venn Therapeutics is a precision medicine company with a broad platform of scientific inquiry targeting cutting edge immuno-oncology (IO). We are developing a pipeline of novel, best-in-class agents that precisely and safely target key mechanisms of cancer, fibrosis and NASH.
XPAT® | Pro-XTEN Platform | T Cell Engagers | Amunix Pharmaceuticals
Amunix is an immuno-oncology company leveraging Pro-XTEN technology platform to discover and develop transformative therapies for patients with cancer.
American Gene Technologies: Developing Gene And Cell Therapies
American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. AGT expects its lead candidate for an **** cure to enter the clinic in 2018, and it has developed a patented immuno-oncology approach to attack a variety of epithelial cancers.
BeiGene | Developing the Next Generation of Cancer Treatments
BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology **** candidates for the treatment of cancer.
Home - Wellstat Therapeutics
WELLSTAT THERAPEUTICS CORPORATION Discover, develop and commercialize products that will provide new and improved treatments for patients in the fields of oncology, metabolic, neurometabolic and neurodegenerative diseases. Learn More COMPANY OVERVIEW Wellstat Therapeutics
Author: Brandadmin
Flash Therapeutics - Recoding Life, Improving Health
Flash Therapeutics is a gene therapy company developing gene and cell-based therapies by leveraging its proprietary lentiviral platform and bioproduction technologies.
Onconova Therapeutics, Inc. - A Biopharmaceutical Company
Onconova Therapeutics, Inc. is focused on discovering and developing novel small molecule **** candidates to treat cancer.
Other sites like harpoontx com
Eureka Therapeutics | ARTEMIS™ | E-ALPHA® | T-cell therapies
Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
IONTAS – Antibody tailoring for success
IONTAS is a biotechnology company focussed on the development of novel antibody therapeutics using phage display and proprietary technology platforms.
Author: Oitentaecinco; Https; Www Oitentaecinco Com
OrphoMed Inc. | Gastrointestinal Disorders | Dimer Therapeutics Platform
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
Home | Vescor Therapeutics
We are a preclinical company focused on the discovery and development of autophagy targeted therapeutics for cancer treatment. Contact us.
Ikena Oncology | Biomarker-Driven Cancer Therapeutics
Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.
Author: Walid
Helix BioPharma - New Directions in Cancer Therapy
We are a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on our proprietary technological platform.
Oncternal Therapeutics | Home
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
IMMUcan - European immuno-oncology profiling platform
IMMUcan, an integrated European immuno-oncology profiling platform Immune checkpoint inhibitors have shown promising results in some cancer types, but biomarkers to select patients that might respond to the treatment are still missing. Similarly, rationales for combining immune checkpoint inhibitors with conventional therapy or targeted agents are lacking. Read more
Author: Frédéric
Welcome to Key Oncologics (Pty) Ltd | Key Oncologics (Pty) Ltd - south africa pharmaceutical treatment oncology cancer allied diseases inter
Key Oncologics (Pty) Ltd is a South African pharmaceutical company that primarily focuses on the treatment of cancer and allied diseases. The company was founded in 1998 representing international companies that do not have an independent presence in Sou
Author: Key Oncologics Pty Ltd
Home - Zumutor Biologics
Zumutor Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. We have two proprietary Antibody Engineering Platforms to develop novel immunotherapies that target innate immunity and regulate the tumor microenvironment. Formed in 2013, we are headquartered at CIC Cambridge Campus, 1 Broadway, Cambridge, MA, USA and an
Author: Zumutor
ViewPoint Therapeutics
ViewPoint Therapeutics is an early stage biotechnology company focused on the development of small molecule treatments for protein misfolding diseases, including cataracts and presbyopia.
Preclinical Oncology CRO | Contract Research **** Development Company - CrownBio
Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for **** development. CrownBio brings clarity to **** discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
Author: Crown Bioscience; Inc
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
A leading Precision Oncology Company| 4baseCare
4baseCare is a leading precision oncology company with a strong focus on personalised cancer treatment using NGS (Next Generation Sequencing) and digital health technology
Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. Our cutting-edge science is fully focused on developing **** therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Join us …
Home - Intellia Therapeutics
Using CRISPR/Cas9 technology, Intellia Therapeutics is developing revolutionary genome editing therapies to cure genetic diseases with simple, targeted treatments.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
Breakthrough miRNA therapeutics tackling cancer - InteRNA Technologies
A Dutch clinical-stage biotech company InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation **** delivery
Procella Therapeutics AB - Cell Therapy Solutions
Procella Therapeutics AB is a biotech company focused on developing cardiac stem cell technology with the aim of treating heart failure.
Home - GammaDelta Therapeutics
OUR MISSION Discover GammaDelta Therapeutics GammaDelta Therapeutics is committed to transforming the treatment of patients living with haematological and solid cancers. Our mission is to develop the first effective off the shelf cancer therapy based on one of the body’s own immune cells, a subtype of gamma delta (γδ) T lymphocyte known as
Author: Gammadelta
What else harpoontx.com alternative websites
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune diseases | Cartesian
Pioneering RNA-Engineered Cell Therapy In and Beyond Oncology Cartesian uses the RNA Armory®, its proprietary cell therapy platform, to engineer combination therapies into cells, and targets these cells precisely to the site of disease. UNDERSTAND OUR SCIENCE Our therapeutic candidates Cartesian
Author: Cartesian
EBVDT Home - Endothelial Biomedicine and Vascular **** Targeting Research
The Endothelial Biomedicine Vascular **** Targeting research group focuses on understanding **** specific, microvascular endothelial cell behaviour in (inflammatory) diseases and cancer, and on the development of therapeutic strategies to selectively interfere with endothelial cell engagement in these diseases.
home - Compugen
From Code to Cure® Using a predictive computational platform to discover untapped **** targets and extend the reach of cancer immunotherapies to new patient populations Pipeline We are advancing new therapeutics and optimizing their combination to expand immuno-oncology treatment options to cancer patients who are refractory or unresponsive to currently available drugs learn more » … home Read More »
Home - Tissue Regeneration Therapeutics
Tissue Regeneration Therapeutics (TRT) is a progressive biotechnology company with a focus on the commercial development of our patented Human Umbilical Cord PeriVascular Cell (HUCPVC) platform technology and its TXP cell therapy products.
TOGETHER, WE’RE MAKING ADIFFERENCE IN CANCER TREATMENT
BeyondSpring is a global, clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with the University of Washington in de novo **** discovery using a ubiquitination platform.
AntlerA Therapeutics: Repair | Regenerate | Renew
A regenerative medicines company focused on developing novel protein therapeutics that function by modulating Wnt signaling and other developmental cellular signaling pathways with the goal to control tissue stem cells and unleash tissue repair and rejuvenation
SystImmune
Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-**** conjugates (ADCs).
Home - Xilis
Informed Choices. Better Outcomes. Developed by world-class scientists from the U.S. and Europe, Xilis’ MicroOrganoSphereTM (MOS) technology and Precision Oncology Platform is transforming treatment choices in the clinic and bringing novel therapeutics to patients.
Kymab
Kymab, based in Cambridge, UK, is working independently and with partners to provide novel solutions in **** and vaccine development. Using our unique technology, we rapidly develop broad diversity, high-quality human antibodies for treating challenging diseases. We are building a rich pipeline of assets in four main therapeutic spaces: immuno-oncology, inflammation, haematology and infectious diseases, with clinical studies expected to begin in 2017.
AzurRx BioPharma
AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. Our therapeutic products will be administered to patients as **** non-systemic biologics.
Home - Alexza Pharmaceuticals
Developing novel therapeutic treatments Alexza Pharmaceuticals is focused on the research, development, and commercialization of novel, proprietary products for the acute treatment of medical conditions. Alexza’s products and development pipeline are based on the Staccato® One Breath Technology™ – OBT™ system, a handheld inhaler designed to deliver a pure **** aerosol to the deep lung, […]
Genprex - Reprogramming the course of cancer and diabetes
Genprex’s oncology **** development program utilizes its unique, proprietary, non-viral ONCOPREX® Nanoparticle Delivery System, which the Company believes is the first systemic gene therapy delivery platform used for cancer in humans.
We build superior ADCs | Iksuda Therapeutics
Iksuda is an emerging biotechnology company focused on developing antibody-based therapies for the treatment of cancer as well as broader based therapeutics. Our main goal is to develop effective therapies to improve patients’ lives. Our mission is to enable improved clinical regimes through cre ...
Author: Base Creative
Ethris – ENABLING mRNA THERAPIES
About Ethris Ethris has paved a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA technology platform to discover, design and develop innovative therapies. With more than a
Author: Ethris
ACM Biolabs
ACM Biolabs is focused at developing novel vaccines and antibodies using their proprietary artificial cell membrane - ACM technology. Incorporate functional, folded membrane proteins into the artificial cell membranes which keep them stable, allowing them to induce a strong immune reaction.
Author: ACM Biolabs
Atara Bio - Home
Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases.Leveraging our novel allogeneic EBV T-cell platform, Atara intends to deliver treatments to patients with high unmet medical need. Our platform aims to leverage the unique biology of EBV T cells to channel the power of the immune system and has the potential to...
Author: August
Altimmune a clinical stage biopharmaceutical company
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Developing novel vaccines and therapeutic proteins | Medicago
Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.
Proprietary Platforms, Frederick, MD
Royer Biomedical Incorporated in Frederick, MD does researches using proprietary polymer platform technologies. We develop existing pharmaceutical compounds in novel formulations for diabetes, orthopedics, cancer, and infections, such as biofilm. Get in touch with us today to learn more.
Home - VTV Therapeutics
vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of **** administered small molecule **** candidates to fill significant unmet medical needs. vTv has a pipeline of internally discovered clinical **** candidates led by programs for the treatment of type 1 diabetes and inflammatory disorders. To learn more about our science […]
Other websites similar as harpoontx.com
Klox Technologies | A Regenerative Medicine Company
Klox Technologies Klox Technologies Inc. is a private regenerative medicine company, advancing the development of its proprietary Fluorescent Light Energy (FLE) platform, also known as Fluorescence Biomodulation, for specific skin/soft tissue conditions and diseases. Our platform has shown to impact cellular signaling pathways, which stimulate the skin’s own biological processes and repair
Author: Jason Campbell
AID Genomics
AID Genomics is an international group of medical technology companies specialized in the diagnosis and therapy of cancer and infectious diseases like COVID-19. AID Genomics’ advanced testing platforms were developed by a leading team of experts in oncology, molecular biology, molecular pathology, genomics and bioinformatics.
Author: Kelvin Wu
SYLENTIS S.A. - RNAi biopharmaceuticals
SYLENTIS, biotechnology company focused on the development of new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. Addressed diseases in its pipeline includes dry eye, retina diseases, glaucoma or allergies. SYLENTIS is one of the pioneer companies devoted to siRNA, with one of the most advanced siRNA design technologies worldwide, researching on an extense range of Ophtalmical Therapeutic areas and indications. Most advanced experimental drugs: Bamosiran and Tivanisiran.
PolyPid - Optimized Therapeutics
ABOUT US We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications […]
Home -
SOLA Biosciences (Greater Boston, MA) is a pre-clinical-stage biopharmaceutical company focusing on developing transformative gene therapies to treat protein misfolding diseases. SOLA developed a proprietary “JUMP70 (J-domain Upholding Misfolding-Protein for Hsp70 Chaperone)” technology platform designed to harness the power of a patient’s own chaperones to repair disease-causing proteins. SOLA is currently developing eight (8) pipeline … Continue reading "Home"
Intuitive Therapeutics - The best assistant for your SRS plan
Intuitive Therapeutics SA is a Swiss high tech and innovative company based in Switzerland. It has developed a novel radiosurgery/radiotherapy inverse planning algorithm capable of an extreme speed, unequalled ease of use and highest productivity. This method brings also more effective solutions in terms of quality and treatment time. The software application, called IntuitivePlan, is suitable for Leksell Gamma Knife®, for CyberKnife® and linear accelerators using IMRT (Intensity Modulated Radiation Therapy) or VMAT (Volumetric-Modulated Arc Therapy). The use of the demonstrator allowed to show the superior capacity of the solutions proposed by our algorithm.
Author: Super User
Intuitive Therapeutics - The best assistant for your SRS plan
Intuitive Therapeutics SA is a Swiss high tech and innovative company based in Switzerland. It has developed a novel radiosurgery/radiotherapy inverse planning algorithm capable of an extreme speed, unequalled ease of use and highest productivity. This method brings also more effective solutions in terms of quality and treatment time. The software application, called IntuitivePlan, is suitable for Leksell Gamma Knife®, for CyberKnife® and linear accelerators using IMRT (Intensity Modulated Radiation Therapy) or VMAT (Volumetric-Modulated Arc Therapy). The use of the demonstrator allowed to show the superior capacity of the solutions proposed by our algorithm.
Author: Super User
Intuitive Therapeutics - The best assistant for your SRS plan
Intuitive Therapeutics SA is a Swiss high tech and innovative company based in Switzerland. It has developed a novel radiosurgery/radiotherapy inverse planning algorithm capable of an extreme speed, unequalled ease of use and highest productivity. This method brings also more effective solutions in terms of quality and treatment time. The software application, called IntuitivePlan, is suitable for Leksell Gamma Knife®, for CyberKnife® and linear accelerators using IMRT (Intensity Modulated Radiation Therapy) or VMAT (Volumetric-Modulated Arc Therapy). The use of the demonstrator allowed to show the superior capacity of the solutions proposed by our algorithm.
Author: Super User
Intuitive Therapeutics - The best assistant for your SRS plan
Intuitive Therapeutics SA is a Swiss high tech and innovative company based in Switzerland. It has developed a novel radiosurgery/radiotherapy inverse planning algorithm capable of an extreme speed, unequalled ease of use and highest productivity. This method brings also more effective solutions in terms of quality and treatment time. The software application, called IntuitivePlan, is suitable for Leksell Gamma Knife®, for CyberKnife® and linear accelerators using IMRT (Intensity Modulated Radiation Therapy) or VMAT (Volumetric-Modulated Arc Therapy). The use of the demonstrator allowed to show the superior capacity of the solutions proposed by our algorithm.
Author: Super User
Home - AdAlta - Developing i-body drugs to treat fibrotic diseases
AdAlta is an innovative, clinical stage biotech company developing a unique range of new **** treatments AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta …
Some websites with similar theme to harpoontx.com include:
Frontotemporal dementia | The Bluefield Project to Cure FTD
The Bluefield Project was established in 2010 to fund research directed towards curing frontotemporal dementia (FTD). FTD is a devastating, early-onset degenerative brain disease and is recognized as a common cause of dementia in people under the age of 60 years.
IWIRC, International Women's Insolvency & Restructuring Confederation
IWIRC, the premier networking organization for women in the practice of insolvency and restructuring, helps its members achieve productive relationships by providing a range of practice development and networking opportunities that enhance their professional stature within an open and friendly culture.
Liver Cancer & T-Cell Therapy | Eureka Connect Me
Learn more about liver cancer and our unique approach to tackling liver cancer at Eureka Connect Me.
Financing Senior Housing Since 1992 | LTC Properties Inc.
LTC Properties is a REIT investing in seniors housing and health care through sale-leasebacks, mortgage financing, joint-ventures, construction financing and structured finance solutions.
Mozart Therapeutics | CD8 T regulatory cells | Autoimmune and Inflammatory diseases
Mozart Therapeutics is capitalizing on a novel CD8 T regulatory cell network to develop innovative disease-modifying therapies for autoimmune and inflammatory diseases.
NovoMedix LLC
NovoMedix is conquering Cancer and Fibrosis by IL-11 inhibition and modulation of key regulatory pathways
Zosano Pharma | Migraine treatment | M207 | zolmitriptan
Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy.
Oncolytic immunotherapy | CG0070 | CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.
Allakos | AK002 mAb
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases
American College of Bankruptcy
The mission of the College is to honor and recognize distinguished bankruptcy professionals who are qualified for membership in an effort to set standards of achievement for others in the insolvency community.
More other alternatives for harpoontx com
Vir Biotechnology
Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Natural Killer Cells (NK Cells) for the treatment of cancer
Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.
Imetelstat | Myelofibrosis | Myelodysplastic Syndrome | Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Rare Genetic Diseases | Ultragenyx
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.
Chinook Therapeutics | Atrasentan
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
Engineering Drugs for Personalized Medicines
Engineering Drugs for Personalized Medicines, Plexxikon has earned a reputation as a leader in targeted **** discovery and translational, personalized medicine.
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Adicet Bio | Gamma Delta T cells
Adicet Bio, a pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.
Bringing ingenuity to drugdevelopment
Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.
Dynavax Technologies | Toll-like Receptor | Vaccines
Dynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
Blade Therapeutics
Blade Therapeutics is advancing innovative anti-fibrotic therapies to meet currently unserved patient needs.
The Protein Design Revolution Begins Here
Neoleukin is a leader in de novo protein design – utilizing advanced computational methods to build entirely new therapeutic proteins tailor-made to treat immunological disorders, including cancer and autoimmunity.
Innovative Targeted and Immune-Mediated Cancer Therapies
Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients.
Communications & Power Industries
Communications & Power Industries (CPI) provides microwave, radio frequency (RF), power and control solutions for defense, communications, medical, scientific and industrial applications. Products include: VEDs, klystrons, TWTs, TWTAs, CFAs, satcom amplifiers, HPAs, SSPAs, LNAs, LNBs, power grid devices, advanced antenna systems, BUCs, solid-state devices, IMAs, EIKs, magnetrons, gyrotrons, medical x-ray generators, medical digital imaging systems, telemetry systems, radomes, transmitters, microwave switches, RF decks, receiver protectors, pressure windows, helix devices, coupled cavity devices
